Global growth is projected at 3.0 percent for 2025 and 3.1 percent in 2026, an upward revision from the April 2025 World Economic Outlook. This reflects front-loading ahead of tariffs, lower effective ...

Canada’s population declined by more than 100,000 people in 2025, marking the first annual decline in records that date back to the 1940s as the federal government tries to rein in the number of ...

Liverpool’s return to the summit of the Premier League last season dovetailed with a return to profitability, and the club’s 2024-25 financials, publicly released last Thursday, unveiled the platform ...

Cryptio secured $45 million in Series B funding as banks and crypto firms seek systems to reconcile blockchain transactions for audits, reporting and tokenized assets.

Rubrik, Inc. ( RBRK) Q4 2026 Earnings Call March 12, 2026 5:00 PM EDT Good afternoon, ladies and gentlemen, and welcome to the Rubrik Fourth Quarter and Fiscal Year 2026 Results Conference Call.

Good day, and welcome to the Kingsway Fourth Quarter 2025 and Full Year Earnings Call. [Operator Instructions] Please note, this conference is being recorded. With me on the call are JT Fitzgerald, ...

Rising costs of home care and nursing homes are pricing out middle-income families, forcing them to take on caregiving responsibilities or tap their savings ...

The company's platform tracks digital assets, storage locations, and crypto loans, enabling financial institutions and ...

Use AARP’s interactive scam-tracking map to easily search for and report scams in your area. Go to Map.

Generated full-year 2025 net product sales of XDEMVY ® of $451.4 million, an increase of more than 150% year-over-year Providing expected XDEMVY peak sales potential of more than $2 billion Extending ...

This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). In general, the measures exclude items and charges ...

CONSHOHOCKEN, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic ...